Cardiology
From the Journals
Statin, antihypertensive treatment don’t guarantee healthier lifestyles
Data from 41,000 Finns showed that people put on a primary CVD-prevention regimen don’t always turn healthier.
Conference Coverage
Heart rhythm data from wearables confounds EP practice
NATIONAL HARBOR, MD. – Cardiac electrophysiologists increasingly see patients who’ve received arrhythmia alerts from wearable devices.
Conference Coverage
Silent ischemia isn’t what it used to be
SNOWMASS, COLO. –
Q&A
Routine heart disease screening not recommended
News
New Vascepa indication opens up treatment to millions; “Most significant event since statins”
From the Journals
Carbs, fat, and mortality: Types matter more than levels
Conference Coverage
Cardiac biomarkers refine antihypertensive drug initiation decisions
PHILADELPHIA – Analysis showcases a better way to select patients for intensive BP lowering.
From the Journals
Adult survivors of childhood cancer are experiencing fewer major cardiac events
Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
From the Journals
Cardiovascular risks associated with cannabis use
Review authors suggest cardiovascular patients may benefit from cannabis screening and testing.
News
FDA approves CV disease benefit for once-weekly semaglutide
The approval was based on data from the SUSTAIN 6 in patients with type 2 diabetes and established heart disease.
Conference Coverage
Are providers asking about menstrual bleeding before/during anticoagulant therapy?